Personalis to Present at Upcoming Investor Conferences

Rhea-AI Summary

Personalis, Inc. (Nasdaq: PSNL) announced its participation in upcoming investor conferences to showcase its advancements in cancer genomics. The company will present at the Bank of America 2022 Healthcare Conference on May 11, 2022, at 6:20 p.m. ET in Las Vegas, and at the UBS Global Healthcare Conference on May 24, 2022, at 3:30 p.m. ET in New York. Personalis is committed to enhancing precision cancer therapies through its innovative NeXT Platform, which evaluates nearly 20,000 human genes from a single sample.

MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the following investor conferences:

• Bank of America 2022 Healthcare Conference
  Presenting on Wednesday, May 11, 2022 at 6:20 p.m. Eastern Time at the Encore Hotel in Las Vegas
  A live audio webcast and replay of the presentation may be accessed for 90 days on the “Investors” section of the company’s website at: https://personalis.com/.

• UBS Global Healthcare Conference 2022
  Presenting on Tuesday, May 24, 2022 at 3:30 p.m. Eastern Time at the Lotte New York Palace Hotel in New York

About Personalis

Personalis, Inc. is a leader in advanced cancer genomics, enabling the next generation of precision cancer therapies and diagnostics. The Personalis NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers and clinicians with information on all of the approximately 20,000 human genes, together with the immune system, from a single sample. To enable cancer sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big data, scale, and efficiency. The laboratory is GxP-aligned as well as Clinical Laboratory Improvement Amendments of 1988-certified and College of American Pathologists-accredited. For more information, visit the Personalis website and follow Personalis on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220428006149/en/

Investor Relations Contact:

Caroline Corner

investors@personalis.com

415-202-5678

Media Contact:

Jennifer Temple

pr@personalis.com

www.personalis.com

650-752-1300

Source: Personalis, Inc.

FAQ

When is Personalis presenting at the Bank of America 2022 Healthcare Conference?

Personalis will present at the Bank of America 2022 Healthcare Conference on May 11, 2022, at 6:20 p.m. Eastern Time.

Where is Personalis' presentation at the UBS Global Healthcare Conference?

Personalis will present at the UBS Global Healthcare Conference on May 24, 2022, at 3:30 p.m. Eastern Time at the Lotte New York Palace Hotel.

What is the focus of Personalis Inc. in cancer genomics?

Personalis focuses on advanced cancer genomics, enabling precise cancer therapies and diagnostics through their NeXT Platform.

What can investors expect from Personalis at the upcoming conferences?

Investors can expect insights into Personalis' advancements in cancer genomics and updates on their NeXT Platform during the upcoming conferences.

How can I access the live presentation from Personalis at the Bank of America conference?

The live audio webcast and replay of Personalis' presentation at the Bank of America conference can be accessed on their website for 90 days.